Vanja Zeremski

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 6

Top Topics

Cross Sectional

Blood Brain Barrier

Diffuse Large B Cell Lymphoma

Top Venues

European journal of haematology

Leukemia & lymphoma

Annals of hematology

Hematological oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Vanja Zeremski, Louisa Adolph, Sina A Beer, Mirjeta Berisha, Benedikt Jacobs, Christoph Kahl, Christian Koenecke, Siegfried Kropf, Jens Peter Panse, Judith Petersen, Martin Schmidt-Hieber, Jessica Schneider, Vladan Vucinic, Jeanette Walter, Oliver Weigert, Hanno M Witte, Dimitrios Mougiakakos
Relevance of different prognostic scores in primary CNS lymphoma in the era of intensified treatment regimens: A retrospective, multicenter analysis of 174 patients. European journal of haematology 112 (4) (2024)
Vanja Zeremski, Louisa Adolph, Sina A Beer, Mirjeta Berisha, Benedikt Jacobs, Christoph Kahl, Christian Koenecke, Siegfried Kropf, Jens Peter Panse, Judith Petersen, Martin Schmidt-Hieber, Jessica Schneider, Vladan Vucinic, Jeanette Walter, Oliver Weigert, Hanno M Witte, Dimitrios Mougiakakos
Relevance of different prognostic scores in primary CNS lymphoma in the era of intensified treatment regimens: A retrospective, multicenter analysis of 174 patients. European journal of haematology (2024)
Vanja Zeremski, Louisa Adolph, Sina A Beer, Mirjeta Berisha, Benedikt Jacobs, Christoph Kahl, Christian Koenecke, Siegfried Kropf, Jens Peter Panse, Judith Petersen, Martin Schmidt-Hieber, Jessica Schneider, Vladan Vucinic, Jeanette Walter, Oliver Weigert, Hanno M Witte, Dimitrios Mougiakakos
Relevance of different prognostic scores in primary CNS lymphoma in the era of intensified treatment regimens: A retrospective, multicenter analysis of 174 patients. European journal of haematology 112 (4) (2024)
Vanja Zeremski, Ellen Darcy McPhail, Thomas M Habermann, Francesca Schieppati, Niklas Gebauer, Theodoros P Vassilakopoulos, Dimitrios Mougiakakos
Treatment intensification might not improve survival in high-grade B-cell lymphoma with a concurrent MYC and BCL2 and/or BCL6 rearrangement: A retrospective, multicenter, pooled analysis. Hematological oncology (2023)
Vanja Zeremski, Kathleen Jentsch-Ullrich, Christoph Kahl, Martin Mohren, Judith Eberhardt, Thomas Fischer, Enrico Schalk
Is bendamustine-rituximab a reasonable treatment in selected older patients with diffuse large B cell lymphoma? Results from a multicentre, retrospective study. Annals of hematology 98 (12) (2019)
Vanja Zeremski, Thomas Fischer, Enrico Schalk
Dose reduction and high-risk disease as risk factors for early death in primary CNS lymphoma. Leukemia & lymphoma 61 (1) (2019)